Found 5 matching trials
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222) N/A The primary purpose of this study is to assess the long-term safety and eff...
Show More Status
Enrolling By Invitation
Location
10-15 Phoenix Childrens Hospital
Learn More & Join Trial
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B PHASE3 This is a phase 3, prospective, open-label, single-arm, single-dose, multic...
Show More Location
Center for Inherited Blood Disorders
Learn More & Join Trial
HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients PHASE3 This is an open-label, single-dose, multi-center, multinational trial to de...
Show More Location
Phoenix Children's Hospital
Learn More & Join Trial
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs) PHASE3 The purpose of this study is to assess the risk of bleeding due to failure ...
Show More Location
University of California, San Diego (UCSD)
Learn More & Join Trial
Dose Confirmation Trial of AAV5-hFIXco-Padua PHASE2 This is an open-label, single-dose, single-arm, multi-center trial, with a ...
Show More Location
Phoenix Childrens Hospital
Learn More & Join Trial